Bo Zhou, PhD

Articles

Formulary Restrictions and Stroke Risk in Patients With Atrial Fibrillation

August 04, 2022

Limiting access to non–vitamin K antagonist oral anticoagulants through step therapy and prior authorization may exacerbate current underuse of anticoagulants and increase the risk of stroke in patients with newly diagnosed atrial fibrillation.